Daily oral cyanocobalamin supplementation in Beagles with hereditary cobalamin malabsorption (Imerslund‐Gräsbeck syndrome) maintains normal clinical and cellular cobalamin status

BACKGROUND: Efficacy of PO cobalamin (Cbl) supplementation in dogs with hereditary Cbl malabsorption (Imerslund‐Gräsbeck syndrome, IGS) is unknown. OBJECTIVES: To evaluate PO Cbl supplementation in Beagles with IGS previously treated parenterally. We hypothesized that 1 mg cyano‐Cbl daily PO would m...

Descripción completa

Detalles Bibliográficos
Autores principales: Kook, Peter H., Hersberger, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430909/
https://www.ncbi.nlm.nih.gov/pubmed/30554416
http://dx.doi.org/10.1111/jvim.15380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430909/
https://www.ncbi.nlm.nih.gov/pubmed/30554416
http://dx.doi.org/10.1111/jvim.15380

Ejemplares similares